SHON Is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy
(2013)
Journal Article
Endocrine therapies are the primary systemic intervention for patients with estrogen receptor–positive (ER+) breast cancer. However, a significant proportion of initially responsive ER+ tumors develop resistance, with relapses occurring in up to 50%... Read More about SHON Is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.